Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinomaR J Motzer, P Lyn, P Fischer, et al.
Cancer|August 15, 1995
all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trialM M Moasser, R J Motzer, K S Khoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Journal of the National Cancer Institute|February 7, 1990
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumorsM Ladanyi, F Samaniego, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiersJ Bacik, M Mazumdar, B A Murphy, et al.
Oncogene|June 6, 2012
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progressionM A López-Lago, S Posner, V J Thodima, et al.
Cancer|December 1, 1993
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trialR J Motzer, E Dmitrovsky, W H Miller, et al.
Cancer|November 11, 1992
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markersD P Wood, H W Herr, R J Motzer, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinomaR J Motzer, P Lyn, P Fischer, et al.
Cancer|August 15, 1995
all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trialM M Moasser, R J Motzer, K S Khoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Journal of the National Cancer Institute|February 7, 1990
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumorsM Ladanyi, F Samaniego, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiersJ Bacik, M Mazumdar, B A Murphy, et al.
Oncogene|June 6, 2012
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progressionM A López-Lago, S Posner, V J Thodima, et al.
Cancer|December 1, 1993
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trialR J Motzer, E Dmitrovsky, W H Miller, et al.
Cancer|November 11, 1992
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markersD P Wood, H W Herr, R J Motzer, et al.
Pageof 16